SCHEMBL763479

SCHEMBL763479

CC(=N)NCc1ccc(Cl)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
GAA P10253 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
MAPT P10636 1/20 0.51
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
FAAH O00519 1/20 0.47
OXTR P30559 1/20 0.44
AVPR1A P37288 1/20 0.44
NAMPT P43490 2/20 0.44
CYP2C9 P11712 1/20 0.44
DGAT1 O75907 1/20 0.42
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27467998 0.83 GAA (0.49) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL9563373 0.83 KDM4E (0.49) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL2632301 0.83 ALDH1A1 (0.57) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL29811285 0.83 ALDH1A1 (0.57) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL27690792 0.82 KDM4E (0.47) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL3704245 0.77 L3MBTL1 (0.56) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL5012151 0.77 FAAH (0.61) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL7662024 0.77 GAA (0.49) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL13846437 0.77 KDM4E (0.49) KDM4EGAAL3MBTL1MAPTALDH1A1
SCHEMBL7865708 0.77 KMT2A (0.47) GAAMAPTALDH1A1SMN1; SMN2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138350-B2 N′-cyano-N-halogenalkylimidamide derivatives BAYER CROPSCIENCE AG (DE) 2012-03-20 US disclosed
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives BAYER CROPSCIENCE AG (DE) 2010-02-25 US disclosed
US-6391327-B1 SYNERGISTIC PESTICIDAL COMPOSITION COMPRISING PRALLETHRIN AND NEONICOTINOID COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-05-21 US disclosed
US-6284782-B1 INSECTICIDES; SYNERGISTIC MIXTURES SUMITOMO CHEMICAL CO., LTD. (JP) 2001-09-04 US disclosed
US-6255340-B1 SYNERGISTIC MIXTURE OF PRALLETHRIN AND A NEONICOTINOID COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives NCLN, NISCH, DDT KDM4E 2289/4885GAA 2313/4885L3MBTL1 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.